FTSE All-Share
5.326,71
PKT
+11,13
PKT
+0,21
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.07.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 07.07.21 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 05.07.21 | Diageo Buy | Jefferies & Company Inc. | |
| 05.07.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 05.07.21 | Rio Tinto Equal Weight | Barclays Capital | |
| 02.07.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 02.07.21 | BAT Outperform | RBC Capital Markets | |
| 02.07.21 | Barclays Outperform | Credit Suisse Group | |
| 01.07.21 | GSK Neutral | UBS AG | |
| 01.07.21 | Vodafone Group Overweight | JP Morgan Chase & Co. | |
| 30.06.21 | Prudential Neutral | JP Morgan Chase & Co. | |
| 30.06.21 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 30.06.21 | Unilever Neutral | JP Morgan Chase & Co. | |
| 30.06.21 | Diageo Outperform | Credit Suisse Group | |
| 29.06.21 | Unilever buy | Goldman Sachs Group Inc. | |
| 29.06.21 | Rio Tinto Hold | Deutsche Bank AG | |
| 29.06.21 | Barclays buy | Goldman Sachs Group Inc. | |
| 28.06.21 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 28.06.21 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 28.06.21 | National Grid Outperform | Bernstein Research | |
| 28.06.21 | National Grid Outperform | RBC Capital Markets | |
| 25.06.21 | Vodafone Group buy | Jefferies & Company Inc. | |
| 25.06.21 | GSK Hold | Deutsche Bank AG | |
| 25.06.21 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 24.06.21 | Vodafone Group buy | Deutsche Bank AG | |
| 24.06.21 | GSK Hold | Kepler Cheuvreux | |
| 24.06.21 | Diageo market-perform | Bernstein Research | |
| 24.06.21 | Diageo buy | UBS AG | |
| 24.06.21 | GSK Neutral | UBS AG | |
| 24.06.21 | GSK verkaufen | Credit Suisse Group | |
| 24.06.21 | Unilever Neutral | JP Morgan Chase & Co. | |
| 24.06.21 | GSK buy | Goldman Sachs Group Inc. | |
| 24.06.21 | GSK Hold | Deutsche Bank AG | |
| 24.06.21 | GSK Underweight | Barclays Capital | |
| 24.06.21 | GSK buy | Jefferies & Company Inc. | |
| 23.06.21 | GSK buy | Goldman Sachs Group Inc. | |
| 23.06.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 23.06.21 | Rio Tinto Equal-Weight | Morgan Stanley | |
| 22.06.21 | BAT Neutral | JP Morgan Chase & Co. | |
| 22.06.21 | GSK Underperform | Credit Suisse Group |